Verastem (VSTM) Stock: Buy, Sell, or Hold?
VSTM - Verastem, Inc.
$7.32
-0.30 (-3.94%)
âŧ
5d:
-8.27%
30d:
+5.32%
90d:
+85.79%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When VSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VSTM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VSTM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: VSTM is currently trading at $7.32, which is considered fair relative to its 30-day fair value range of $6.42 to $7.76.
Technical Outlook: Technically, VSTM is in a strong uptrend. Immediate support is located at $7.00, while resistance sits at $8.54. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: VSTM scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.00 (+104.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VSTM is in a strong uptrend. Immediate support is located at $7.00, while resistance sits at $8.54. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: VSTM scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.00 (+104.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.42 -
$7.76
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
Protect Your Profits
Holding VSTM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 104.9% below Wall St target ($15.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.42 -
$7.76
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.00
Resistance Level
$8.54
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.76
Wall Street Target
$15.00
(+104.9%)
Revenue Growth (YoY)
1775.4%
Profit Margin
-231.6%
Share & Embed Analysis
Last updated: September 12, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$370 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$570 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$315 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced VSTM Option Strategies
Professional options setups generated by AI based on today's VSTM price and gamma walls.
